Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Methylnaltrexone”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00402038
What this trial is testing

Study of Methylnaltrexone (MNTX) for the Relief of Constipation

Who this might be right for
Advance Illness Patients With OIC
Bausch Health Americas, Inc. 134
Post-approval studies (Phase 4)UnknownNCT03283020
What this trial is testing

Opioid-Induced Swallowing Dysfunction - The Impact of Bolus Volume

Who this might be right for
Pharyngeal DysfunctionPharyngeal Swallowing
Region Örebro County 20
Testing effectiveness (Phase 2)Study completedNCT01367587
What this trial is testing

Safety and Gastrointestinal Effects of Intravenous Methylnaltrexone

Who this might be right for
Healthy Volunteers
Bausch Health Americas, Inc. 12
Large-scale testing (Phase 3)Study completedNCT00936884
What this trial is testing

Study Evaluating the Efficacy and Safety of Subcutaneous Methylnaltrexone (MOA-728) for the Treatment of Opioid-Induced-Constipation

Who this might be right for
Constipation
Bausch Health Americas, Inc. 50
Post-approval studies (Phase 4)Study completedNCT03523520
What this trial is testing

Methylnaltrexone vs Naloxegol in the Treatment of Opioid-Induced Constipation

Who this might be right for
Constipation Drug Induced
University of Missouri-Columbia 15
Post-approval studies (Phase 4)Study completedNCT01773096
What this trial is testing

Methylnaltrexone Use for Opioid-induced Postoperative Constipation

Who this might be right for
Constipation
Shriners Hospitals for Children 60
Not applicableStudy completedNCT01368562
What this trial is testing

Compassionate Use Study of Methylnaltrexone

Who this might be right for
Opioid-induced Constipation
Bausch Health Americas, Inc. 26
Testing effectiveness (Phase 2)Study completedNCT01004393
What this trial is testing

Methylnaltrexone for Opioid-induced Constipation in Cancer Patients

Who this might be right for
NeoplasmsConstipationOpioid-Related Disorders
University of Vermont 12
Early research (Phase 1)Study completedNCT01015222
What this trial is testing

Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced Malignancies

Who this might be right for
Advanced Cancer
M.D. Anderson Cancer Center 122
Early research (Phase 1)Study completedNCT01366339
What this trial is testing

Tolerance and Pharmacokinetics Study of MNTX Tablets

Who this might be right for
Normal Healthy Volunteers
Bausch Health Americas, Inc. 37
Early research (Phase 1)Study completedNCT01367483
What this trial is testing

Study of the Pharmacokinetics of Intravenous Administered 14C-MNTX

Who this might be right for
Healthy Male Volunteers
Bausch Health Americas, Inc. 6
Early research (Phase 1)Study completedNCT01367561
What this trial is testing

Naloxone and Intravenous Methylnaltrexone Effects on Bladder Function

Who this might be right for
Healthy Males
Bausch Health Americas, Inc. 15
Large-scale testing (Phase 3)UnknownNCT01050595
What this trial is testing

Methylnaltrexone for Treatment of Opiate-Induced Constipation in the Intensive Care Unit

Who this might be right for
Opioid-induced Constipation
St. John Health System, Michigan 80
Large-scale testing (Phase 3)WithdrawnNCT04151719
What this trial is testing

An Extension Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Bausch Health Americas, Inc.
Testing effectiveness (Phase 2)Study completedNCT01367548
What this trial is testing

Intravenous (IV) Methylnaltrexone (MNTX) in the Prevention of Post-Operative Ileus

Who this might be right for
Postoperative Ileus
Bausch Health Americas, Inc. 65
Early research (Phase 1)Study completedNCT01889290
What this trial is testing

Methylnaltrexone Pharmacokinetics in Neurointensive Care Patients

Who this might be right for
Opioid Use, Unspecified With Other Opioid-induced Disorder
University of Zurich 9
Testing effectiveness (Phase 2)Study completedNCT00640146
What this trial is testing

Study of Subcutaneous Methylnaltrexone (MNTX) in the Treatment of Opioid-Induced Constipation During Rehabilitation After Orthopedic Procedures

Who this might be right for
Opioid-induced Constipation
Bausch Health Americas, Inc. 37
Not applicableStudy completedNCT03014843
What this trial is testing

The Effect of Naloxone and Methylnaltrexone on Esophageal Sensitivity in Health

Who this might be right for
Endogenous and Esophageal Sensitivity
Universitaire Ziekenhuizen KU Leuven 12
Early research (Phase 1)Study completedNCT01366378
What this trial is testing

Effect of Cimetidine on the Single-Dose PK of IV- Administered MNTX

Who this might be right for
Healthy Adult Subjects
Bausch Health Americas, Inc. 18
Post-approval studies (Phase 4)WithdrawnNCT00949377
What this trial is testing

Can Methylnaltrexone Safely Treat Opioid Related Constipation in the Emergency Department?

Who this might be right for
Colonic Inertia
Beth Israel Medical Center
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation